Stephen W Webster's Net Worth

$6.48 Million

Estimate Recalculated May 17, 2024 09:00PM EST

Who is Stephen W Webster?

Stephen W Webster has an estimated net worth of $6.48 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Cullinan Oncology, Inc., Viking Therapeutics, Inc., Spark Therapeutics, Inc., Nabriva Therapeutics plc, TCR2 THERAPEUTICS INC., NextCure, Inc., OPTIMER PHARMACEUTICALS INC, ADOLOR CORP, and HEARUSA INC.

SEC CIK

Stephen W Webster's CIK is 0001438421

Past Insider Trading and Trends

2017 was Stephen W Webster's most active year for acquiring shares with 12 total transactions. Stephen W Webster's most active month to acquire stocks was the month of December. 2017 was Stephen W Webster's most active year for disposing of shares, totalling 12 transactions. Stephen W Webster's most active month to dispose stocks was the month of November. 2011 saw Stephen W Webster paying a total of $218,800.00 for 153,750 shares, this is the most they've acquired in one year. In 2011 Stephen W Webster cashed out on 411,250 shares for a total of $1,195,312.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
No matching records found

Cullinan Oncology, Inc. (CGEM) Snapshot price: $18.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found

Viking Therapeutics, Inc. (VKTX) Snapshot price: $24.405

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
8K
$5.21
$41,712.00
8K
May 29
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Apr 28
Form 3
—
0
—
—
0
No matching records found

Spark Therapeutics, Inc. No price found

CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.10K
$114.50
-$698,679.00
0
Dec 17
Form 4
+68.80%
2.49K
$45.08
-$56,936.04
6.1K
Jan 18
Form 4
—
0
—
—
0
Jan 15
Form 4
+44.60%
1.11K
$50.55
-$32,099.25
3.62K
Jan 18
Form 4
—
0
$36.80
-$666,900.00
2.5K
Scheduled
Nov 16
Form 4
—
0
$41.42
-$759,300.00
2.5K
Scheduled
Aug 15
Form 4
—
0
$37.29
-$158,144.79
2.5K
Scheduled
Jul 31
Form 4
—
0
$31.73
-$433,342.65
2.5K
Scheduled
Jun 19
Form 4
—
0
$29.32
-$517,282.44
2.5K
Scheduled
Apr 24 - Apr 25
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
$26.92
-$938,820.00
2.5K
May 20
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
$26.16
-$908,200.00
2.5K
Oct 7
Form 4
—
0
—
—
0
Mar 16
Form 4
∞
2.5K
$23.00
$57,500.00
2.5K
Feb 4
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.0002

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-40.61%
-7.83K
$0.19
-$1,486.94
11.45K
Aug 2
Form 4
-3.88%
-777.00
$1.20
-$932.40
19.27K
Aug 2
Form 4
+686.27%
17.5K
—
—
20.05K
Jul 28
Form 4
+218.75%
17.5K
—
—
25.5K
Jul 29
Form 4
—
0
—
—
0
Jul 31
Form 4
∞
8K
$4.59
$36,720.00
8K
May 23
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found